Robert Langreth

Stay informed with Robert Langreth’s coverage and analysis for Fortune.

Page 2 of 4

02 September 2021, Berlin: A physician’s assistant draws up a shot of Johnson & Johnson’s Janssen Corona vaccine against the Corona virus in a primary care physician’s office. According to a study, a third vaccination should significantly increase protection against Corona. It has been unclear how long the Corona vaccine protection will last and when and how often the booster shot will be due. From September 2021, certain groups in Germany will be able to receive a booster vaccination against Covid-19. Photo: Wolfgang Kumm/dpa (Photo by Wolfgang Kumm/picture alliance via Getty Images)

J&J says COVID booster dose provides 100% protection against severe disease

By Robert Langreth and Bloomberg

Pfizer headquarters

FDA panel recommends COVID-19 boosters only for those 65 and older or at high risk

By Robert Langreth, Fiona Rutherford, and others

Reading, PA – August 18: Syringes and a vial of Moderna COVID-19 vaccine. During a COVID-19 vaccine clinic held at the Penn State Health St. Joseph Downtown Campus in Reading Wednesday afternoon August 18, 2021. (Photo by Ben Hasty/MediaNews Group/Reading Eagle via Getty Images)

Moderna files for FDA authorization for a third-dose COVID booster shot

By Robert Langreth and Bloomberg

This picture taken on July 12, 2021 shows a view of a vial of the Pfizer-BioNTech COVID-19 coronavirus vaccine on a table next to a low dead space syringe at the outpatient clinics of the Cardiovascular Centre at Sheba Medical Center near Tel Aviv, Israel. – Israel on July 12 began administering a third shot of the Pfizer-BioNTech coronavirus vaccine to patients with compromised immune systems, as cases in the country rise, the health ministry said. Those immediately eligible for a third shot include people who have had heart, lung and kidney transplants and some cancer patients. (Photo by JACK GUEZ / AFP) (Photo by JACK GUEZ/AFP via Getty Images)

Pfizer submits early data on the effects of third booster dose to FDA

By Riley Griffin, Robert Langreth, and others

Close up of a senior woman getting vaccinated by a female doctor

FDA to green-light a third COVID shot for those with compromised immune system

By Robert Langreth, Josh Wingrove, and others

Signage is displayed on the Moderna Inc. headquarters in Cambridge, Massachusetts, U.S., on Monday, May 25, 2020. An experimental coronavirus vaccine from Moderna Inc. may wind up being “good enough” to be the first authorized inoculation, but is unlikely to be the best, an Evercore ISI analyst said. Photographer: Adam Glanzman/Bloomberg

Moderna plans to build a vaccine factory in Canada that produces COVID shots

By Robert Langreth and Bloomberg

Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. (Photo by Cristina Arias/Cover/Getty Images)

Eli Lilly’s shares rises to highest since June as Alzheimer’s treatment nears final-stage trial

By Robert Langreth and Bloomberg

An Iraqi medic picks an oxygen bottle for a COVID-19 patient at a hospital in the northern Iraqi city of Dohuk, about 260 miles (430 kilometers) northwest of the capital, on July 27, 2021. – More than 1.5 million people have now tested positive and 18,347 have officially died of COVID-19 in Iraq, where the health infrastructure is dilapidated and much of the 40 million population remains sceptical of vaccines. (Photo by SAFIN HAMED / AFP) (Photo by SAFIN HAMED/AFP via Getty Images)

How COVID-19 came raging back in 2021

By James Paton, Robert Langreth, and others

Pfizer vaccine

Pfizer will seek FDA approval of a COVID vaccine booster shot in August

By Robert Langreth and Bloomberg

GUANGZHOU, CHINA – JUNE 03: Medical staffs check nucleic acid test samples in an air-inflated mobile COVID-19 test lab, known as the “Falcon labs”, in Guangzhou Gymnasium on June 3, 2021 in Guangzhou, Guangdong Province of China. (Photo by Chen Jimin/China News Service via Getty Images)

Early coronavirus samples were removed from a U.S. database at the request of Chinese researchers

By Rachel Chang, Robert Langreth, and others

LIVINGSTON, MT – APRIL 01: A Moderna vaccination is prepared at the Park County Health Department vaccination center at the Rodeo-Fairgrounds on April 1, 2021 in Livingston, Montana. Today marks the first day vaccinations in Montana were open to residents age 16 and over. (Photo by William Campbell/Getty Image)

Moderna COVID vaccine up to 100% effective in teens

By Robert Langreth and Bloomberg

Novavax shares soar after strong trial results for COVID-19 vaccine

By Bloomberg and Robert Langreth

The Moderna COVID-19 vaccine at the King’s Point retirement home in Delray Beach, Florida, U.S., on Wednesday, Dec. 30, 2020. The U.S. is vaccinating an average of only 200,000 people a day against COVID-19, and many states have used just a small percentage of the shipments sent to them this month.<br />
Saul Martinez—Getty Images

Moderna raises 2021 vaccine output outlook to at least 600 million doses

By Robert Langreth and Bloomberg

UKRAINE – 2020/12/15: In this photo illustration, vials seen displayed in front of the Food and Drug Administration (FDA) of the United States and Moderna biotechnology company’s logos. FDA finds the COVID-19 vaccine.

Moderna vaccine cleared in U.S., boosting immunization effort

By Anna Edney, Robert Langreth, and others

Moderna to request clearance for COVID-19 vaccine in U.S. and EU

By Bloomberg and Robert Langreth